COMMUNIQUÉS West-GlobeNewswire

Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET
04/05/2026
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
04/05/2026
HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
Brainway Launches Personalized Anti-Procrastination App Grounded in CBT, Earns 6,000+ User Reviews
04/05/2026
Inside the Productivity App Procrastinators Are Calling a Game-Changer – Reviews, Features, and What Sets It Apart NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Brainway is a productivity app helping people stop [...]
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
04/05/2026
Raanana, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing Clinic
04/05/2026
VANCOUVER, British Columbia, May 04, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices [...]
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
04/05/2026
Post-closing combined company has revenue-producing commercial asset and a robust pipeline of products and product candidates to address multiple therapeutic areas with a focus on fibrosis and inflammatory diseases. [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
04/05/2026
COPENHAGEN, Denmark, May 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares for an amount up to [...]
Mother’s Day Gifting Is Changing: From Symbolic Presents to Meaningful Relief — Bob and Brad Marks the Occasion with Up to 30% Off Wellness Devices
04/05/2026
WINONA, Minn., May 04, 2026 (GLOBE NEWSWIRE) -- Mother’s Day gifting is undergoing a subtle shift, with more consumers moving beyond traditional symbolic presents toward products that offer practical, everyday relief. [...]
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
04/05/2026
Successful partnership continues as bispecific antibody candidate moves to GMP manufacturing; project highlights Japan's advanced capabilities in bioprocessing and AGC Biologics' expanding global network CHIBA, Japan, [...]
Halo Care Skin Tag Remover Claims Evaluated: The Strongest, Most Effective Mole & Skin Tag Corrector Serum
02/05/2026
Halo Care Skin Tag Remover Sanguinaria Canadensis and Zincum Muriaticum Formula Explained: 2026 Pricing, Refund, and Dermatologist Guidance New York, NY, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support
02/05/2026
VisioCore Vision Support Supplement Ingredients, Lutein and Zeaxanthin Formula, Pricing, Official Website Access, and 60-Day Guarantee Explained for 2026 Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements [...]
MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk
02/05/2026
MemoPryl Scam Searches, Complaints, and Side Effects Risk Explained for Adults Comparing Nootropic Memory Supplements in 2026 Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the [...]
Milken Institute Global Conference 2026 Set to Open Tomorrow in Beverly Hills with KFSH Participation
02/05/2026
BEVERLY HILLS, Calif., May 02, 2026 (GLOBE NEWSWIRE) -- The Milken Institute Global Conference 2026 is set to open tomorrow in Beverly Hills, bringing together a global cross section of leaders from healthcare, finance [...]
Avicanna Announces Change in Board of Directors
02/05/2026
TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation [...]
Gala GLP-1 Weight Loss Claims Evaluated: The Most Trusted GLP1 Tirzepetide Telehealth Prescription Treatment & Tracker Provider
01/05/2026
How Gala GLP-1's Compounded Tirzepatide and Semaglutide Telehealth Plans Work: Licensed Providers, $179/Mo Pricing, No Insurance Required, and Access in All 50 States in 2026 Wilmington, Delaware, May 01, 2026 (GLOBE [...]
Derma Essential Claims Evaluated: Investigating the Ingredients Inside DermaEssential Healthy Skin Support Formula
01/05/2026
How Derma Essential's Biotin, Vitamin C, Zinc, and Horsetail Extract Formula Is Structured — Ingredients, Pricing, and Guarantee Explained for 2026 Largo, FL, May 01, 2026 (GLOBE NEWSWIRE) -- These statements have not [...]
Tstrive Review: A New Balanced Look at the Men’s Vitality and Energy Supplement
01/05/2026
NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- Low energy, slower metabolism, and a gradual drop in motivation are issues many men face with age or stress. Lifestyle changes such as better sleep and nutrition help, but some [...]
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
01/05/2026
BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
CAMBRIDGE, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]

Pages